Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment.
暂无分享，去创建一个
G. Kazemier | B. Ylstra | E. Thunnissen | D. van den Broek | D. Pegtel | D. Heideman | R. V. van Boerdonk | I. Bahce | J. Weiss | E. van Dijk | Jamie J Beagan | S. Bach